The Pros and Cons of Diagnosing Diabetes With A1C
暂无分享,去创建一个
[1] J. Tuomilehto,et al. Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c. , 2004, Journal of clinical epidemiology.
[2] Lei Zhang,et al. Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China , 2009, Diabetes Care.
[3] J. Shaw,et al. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study , 2009, Diabetologia.
[4] K. Reynolds,et al. Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults , 2009, Diabetes Care.
[5] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.
[6] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[7] K. Eriksson,et al. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise , 1998, Diabetologia.
[8] S. Yusuf,et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. , 2003, Diabetes care.
[9] J. Tuomilehto,et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[10] R. Little,et al. Biological variation of glycohemoglobin. , 2002, Clinical chemistry.
[11] B. Davies,et al. European Association for the Study of Diabetes , 1984 .
[12] E. Ford,et al. Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.
[13] R. Hanson,et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.
[14] John M. Lachin,et al. Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program , 2007 .
[15] Mathias M. Müller,et al. Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement , 2007, Diabetes Care.
[16] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[17] V. Mohan,et al. Moving to an A1C-Based Diagnosis of Diabetes Has a Different Impact on Prevalence in Different Ethnic Groups , 2009, Diabetes Care.
[18] M. Rewers,et al. A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors , 2010, Diabetes Care.
[19] D. Bruns,et al. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. , 2008, Clinical chemistry.
[20] T. Valle,et al. Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial , 2009, PloS one.
[21] J. Eriksson,et al. HbA1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[22] D. Katritsis,et al. Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants , 2006, Clinical chemistry and laboratory medicine.
[23] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[24] David E Bruns,et al. Stabilization of glucose in blood samples: why it matters. , 2009, Clinical chemistry.
[25] Timothy M Reynolds,et al. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. , 2004, Diabetes care.
[26] L. Groop,et al. The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes , 2010, Diabetes/metabolism research and reviews.
[27] Lothar Siekmann,et al. State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. , 2008, Archives of pathology & laboratory medicine.
[28] M. Hanefeld,et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up , 1996, Diabetologia.
[29] G. Bicescu. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, Maedica.
[30] V. Mohan,et al. A1C Cut Points to Define Various Glucose Intolerance Groups in Asian Indians , 2009, Diabetes Care.
[31] L. Bouter,et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.
[32] Ciprian M Crainiceanu,et al. Short-term variability in measures of glycemia and implications for the classification of diabetes. , 2007, Archives of internal medicine.
[33] A. Karter,et al. Hemoglobin A 1 c between 5 . 7 and 6 . 4 % as a marker for identifying prediabetes , insulin sensitivity and secretion , and cardiovascular risk factors : The Insulin Resistance Atherosclerosis Study ( IRAS ) , 2010 .
[34] M. Engelgau,et al. Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited , 1997, Diabetes Care.
[35] N. Day,et al. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.